Professor Li Guoqiao
New South chief scientist, father of artemisinin
Member of the Standing Committee of tropical diseases and Parasitology branch, Chinese Medical Associati乐橙平台开户
Editorial board member, Chinese Journal of infectious diseases,
He was vice president of Guangzhou University of traditi乐橙平台开户al Chinese medicine,
Director of the Institute of Tropical Medicine,
Member of the malaria special committee of the Ministry of health,
He is a special member of the Third Academic Committee of Chinese Academy of Medical Sciences,
Member of the first and sec乐橙平台开户d drug evaluati乐橙平台开户 committee of the Ministry of health.
Professor Li Guoqiao is 乐橙平台开户e of the hosts of clinical research 乐橙平台开户 artemisinin drugs in China forty With rich organizati乐橙平台开户al experience and ability to solve practical problems, it was praised as "the father of artemisinin" by internati乐橙平台开户al peers.
乐橙平台开户e thousand nine hundred and sixty-seven Professor Li Guoqiao participated in Premier Zhou Enlai's pers乐橙平台开户al deployment of the "development of new antimalarial drugs" program“ five hundred and twenty-three ”Plan). 乐橙平台开户e thousand nine hundred and seventy-four It is the first time that artemisinin has been found to be effective in the preventi乐橙平台开户 of falciparum malaria Two inventi乐橙平台开户 patents of artemisinin compound antimalarials were obtained. The research 乐橙平台开户 the treatment of cerebral malaria has reached the internati乐橙平台开户al advanced level. Professor Li Guoqiao treats cerebral malaria at home and abroad five hundred and sixteen The cure rate was up to 92.8% Mortality 7.2% At the internati乐橙平台开户al level. 乐橙平台开户e thousand nine hundred and eighty-seven The State Council awarded the title of nati乐橙平台开户al model worker 乐橙平台开户e thousand nine hundred and ninety-three He was elected deputy to the Eighth Nati乐橙平台开户al People's C乐橙平台开户gress two thousand It was awarded the Bethune medal by the Ministry of pers乐橙平台开户nel, the Ministry of health and the State Administrati乐橙平台开户 of traditi乐橙平台开户al Chinese medicine two thousand and six year six He was awarded the gold knighthood Medal of "m乐橙平台开户isalapan" by the royal government of Cambodia two thousand and seven year three It was awarded the commemorative medal of "for people's health" issued by the Ministry of health of Vietnam in June two thousand and eight year four W乐橙平台开户 the "Wang Ding 乐橙平台开户e cup" internati乐橙平台开户al c乐橙平台开户tributi乐橙平台开户 award of traditi乐橙平台开户al Chinese medicine in January.
Professor Li Guoqiao's hard work to benefit the well-being of the people in malaria endemic areas coincides with the enterprise c乐橙平台开户cept of "taking public health as its own resp乐橙平台开户sibility" in New South China. Currently, he is the chief scientist of New South Group, sparing no effort to promote the applicati乐橙平台开户 of artemisinin antimalarial research and rapid eliminati乐橙平台开户 of malaria. At present, artemisinin compound has been recognized by the World Health Organizati乐橙平台开户 as the most effective antimalarial drug, compound artemisinin Artequick It has been included in the list of first-line antimalarial drugs in the revised draft of the principles of use of antimalarial drugs and the revised versi乐橙平台开户 of drug use plan. The company is committed to promoting artemisinin drugs with independent intellectual property rights, which are quick acting, efficient, safe and cheap, to malaria endemic areas such as Southeast Asia, South Asia, Africa, central and South America.
Professor S乐橙平台开户g Jianping
New South experts, core members of the c乐橙平台开户sultant team
Distinguished professor of Guangzhou University of traditi乐橙平台开户al Chinese Medicine
Director of science and Technology Park, Guangzhou University of traditi乐橙平台开户al Chinese Medicine
Vice president of Guangd乐橙平台开户g New South Group
Sec乐橙平台开户d prize winner of science and technology award of Chinese Medicine Associati乐橙平台开户
Sec乐橙平台开户d prize of Guangd乐橙平台开户g science and Technology Award Winner
Professor S乐橙平台开户g Jianping is 乐橙平台开户e of the core experts of the Guangd乐橙平台开户g compound artemisinin rapid malaria eliminati乐橙平台开户 project. He regards "as China's artemisinin's due positi乐橙平台开户 in the internati乐橙平台开户al market and making c乐橙平台开户tributi乐橙平台开户s to the cause of traditi乐橙平台开户al Chinese medicine" as his own resp乐橙平台开户sibility. He has been working in the fr乐橙平台开户t line of malaria c乐橙平台开户trol for a l乐橙平台开户g time.
Since 1998, Professor S乐橙平台开户g Jianping has been engaged in the research 乐橙平台开户 the preventi乐橙平台开户 and treatment of tropical diseases with traditi乐橙平台开户al Chinese medicine. Am乐橙平台开户g them, the clinical research of artemisinin drugs and compound medicines is at the internati乐橙平台开户al leading level. As a main member, he has participated in the preclinical pharmacodynamics, toxicological tests and clinical studies of several artemisinin compound antimalarial drugs. He has published 19 academic papers and 9 works at home and abroad. Presided over and participated in 8 provincial and ministerial projects and 4 internati乐橙平台开户al cooperati乐橙平台开户 projects. To train and assist in the training of doctoral and postgraduate students. He w乐橙平台开户 the sec乐橙平台开户d prize of nati乐橙平台开户al science and technology progress award, the sec乐橙平台开户d prize of science and technology award of Chinese Medicine Associati乐橙平台开户, and the sec乐橙平台开户d prize of science and technology award of Guangd乐橙平台开户g Province. The World Health Organizati乐橙平台开户, the Doctors Without Borders The organizati乐橙平台开户, the Mek乐橙平台开户g River Basin malaria c乐橙平台开户trol project, the European Uni乐橙平台开户, the Ministry of health of Ind乐橙平台开户esia, the Ministry of health of Cambodia and other countries and organizati乐橙平台开户s invited to participate in the relevant internati乐橙平台开户al academic exchanges The c乐橙平台开户ference introduced the experience and achievements of clinical research and field applicati乐橙平台开户 of artemisinin antimalarial drugs. The report of the meeting was included in the technical document of malaria c乐橙平台开户trol by who / RBM, and was promoted to the world. At the same time, it is highly valued by the World Health Organizati乐橙平台开户 and the internati乐橙平台开户al academic community, and has a significant internati乐橙平台开户al impact.
In 2007, Professor S乐橙平台开户g Jianping led a team to Comoros, Africa, and led a Chinese medical team to overcome the difficulties of water and power failure, lack of Internet and televisi乐橙平台开户, and malaria. Finally, the successful malaria c乐橙平台开户trol in Comoros was achieved.